Neovacs Begins a Phase I/II Clinical Trial for the Treatment of Crohn’s Disease

Neovacs has announced that it had begun a phase I/II clinical study at three study centres in South Africa with the candidate TNFa-kinoid, a therapeutic vaccine for the treatment of TNFa dependent auto-immune diseases such as rheumatoid arthritis, Crohn’s disease and psoriasis.

This study, to be conducted on patients suffering from Crohn’s disease, will relate to the identification of the optimal immunogenic dosage for neutralizing TNFa.